UnitedHealth Group faces investor uncertainty after reporting a significant profit decline and becoming the subject of a Department of Justice investigation into its Medicare business. The company's upcoming earnings release is crucial, as investors seek reassurance and a clear strategy for recovery. This follows a recent abrupt CEO change and a substantial drop of over 40% in UnitedHealth's stock value, further amplifying investor concerns.